Neutrophils provide a critical line of defense in immune responses to various pathogens, inflicting self-damage upon transition to a hyperactivated, procoagulant state. Recent work has highlighted proinflammatory neutrophil phenotypes contributing to lung injury and acute respiratory distress syndrome (ARDS) in patients with coronavirus disease 2019 (COVID-19). Here, we use state-of-the art mass spectrometry-based proteomics and transcriptomic and correlative analyses as well as functional in vitro and in vivo studies to dissect how neutrophils contribute to the progression to severe COVID-19. We identify a reinforcing loop of both systemic and neutrophil intrinsic IL-8 (CXCL8/IL-8) dysregulation, which initiates and perpetuates neutrophil-driven immunopathology. This positive feedback loop of systemic and neutrophil autocrine IL-8 production leads to an activated, prothrombotic neutrophil phenotype characterized by degranulation and neutrophil extracellular trap (NET) formation. In severe COVID-19, neutrophils directly initiate the coagulation and complement cascade, highlighting a link to the immunothrombotic state observed in these patients. Targeting the IL-8-CXCR-1/-2 axis interferes with this vicious cycle and attenuates neutrophil activation, degranulation, NETosis, and IL-8 release. Finally, we show that blocking IL-8-like signaling reduces severe acute respiratory distress syndrome of coronavirus 2 (SARS-CoV-2) spike protein-induced, human ACE2-dependent pulmonary microthrombosis in mice. In summary, our data provide comprehensive insights into the activation mechanisms of neutrophils in COVID-19 and uncover a self-sustaining neutrophil-IL-8 axis as a promising therapeutic target in severe SARS-CoV-2 infection.
- Kaiser, R.
- Leunig, A.
- Pekayvaz, K.
- Popp, O.
- Joppich, M.
- Polewka, V.
- Escaig, R.
- Anjum, A.
- Hoffknecht, M. L.
- Gold, C.
- Brambs, S.
- Engel, A.
- Stockhausen, S.
- Knottenberg, V.
- Titova, A.
- Haji, M.
- Scherer, C.
- Muenchhoff, M.
- Hellmuth, J. C.
- Saar, K.
- Schubert, B.
- Hilgendorff, A.
- Schulz, C.
- Kääb, S.
- Zimmer, R.
- Hübner, N.
- Massberg, S.
- Mertins, P.
- Nicolai, L.
- Stark, K.
Keywords
- Animals
- COVID-19/complications/*metabolism/pathology
- Humans
- Interleukin-8/*metabolism
- Lung/*immunology/pathology
- Mice
- Neutrophil Activation
- Neutrophils/*immunology/pathology
- Phenotype
- *SARS-CoV-2
- Thrombosis/*etiology/pathology
- *covid-19
- *Cytokines
- *Neutrophils
- *Proteomics
- *Vascular Biology